AnaptysBioANAB
那斯達克 · USD
26.13
-0.46
(-1.73%)
盤中 07/30 03:33 (UTC+8)
07/30 03:33 (UTC+8)
AnaptysBioANAB
26.13
-0.46
(-1.73%)
財務數據
損益表
- 0.07
- 0.01
- 0.03
- 0.03
- 0.09
- 0.07
- 0.11
- 0.30
- 0.43
- 0.28
- 426.53
- -79.82
- 151.82
- -4.10
- 171.40
- -20.28
- 52.82
- 173.60
- 43.63
- -35.59
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 27,771 | 43,113 | 30,017 | 10,971 | 7,179 | 9,005 | 3,318 | 3,460 | 1,374 | 6,808 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 27,771 | 43,113 | 30,017 | 10,971 | 7,179 | 9,005 | 3,318 | 3,460 | 1,374 | 6,808 |
營業費用 | 55,310 | - | 52,774 | - | - | 51,140 | 41,050 | 43,603 | 45,775 | 32,781 |
研發費用 | 41,180 | 42,589 | 42,212 | 41,997 | 37,042 | 33,525 | 30,878 | 32,923 | 34,957 | 23,374 |
推銷及管理費用 | 14,130 | 10,194 | 10,562 | 9,295 | 12,338 | 10,276 | 10,172 | 10,680 | 10,818 | 9,407 |
非經常性項目費用 | - | - | - | - | - | 7,339 | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -27,539 | -9,670 | -22,757 | -40,321 | -42,201 | -42,135 | -37,732 | -40,143 | -44,401 | -25,973 |
其他收入及費用 | 6,315 | 5,284 | 5,319 | 4,623 | 4,582 | 4,878 | 4,855 | 4,656 | 4,482 | 3,835 |
利息費用 | 18,061 | 17,404 | 15,413 | 10,953 | 6,317 | 4,958 | 4,431 | 4,358 | 4,336 | 4,251 |
稅前純益 | -39,285 | -21,790 | -32,851 | -46,651 | -43,936 | -42,215 | -37,308 | -39,845 | -44,255 | -26,389 |
所得稅 | 44 | -6 | - | 9 | - | -4 | - | - | - | 24 |
稅後純益 | -39,329 | -21,784 | -32,851 | -46,660 | -43,936 | -42,211 | -37,308 | -39,845 | -44,255 | -26,413 |
基本每股稅後盈餘(元) | -1.28 | -0.72 | -1.14 | -1.71 | -1.64 | - | -1.41 | -1.50 | -1.58 | -0.93 |
稀釋每股稅後盈餘(元) | -1.28 | -0.66 | -1.11 | -1.71 | -1.64 | -1.59 | -1.41 | -1.50 | -1.58 | -0.93 |
基本平均股數(千股) | 30644.00 | 30448.00 | 28893.00 | 27356.00 | 26801.00 | - | 26546.00 | 26629.00 | 27953.00 | 28446.00 |
稀釋平均股數(千股) | 30644.00 | 30448.00 | 28893.00 | 27356.00 | 26801.00 | - | 26546.00 | 26629.00 | 27953.00 | 28446.00 |
還原基本每股稅後盈餘(元) | -1.28 | -0.72 | -1.14 | -1.71 | -1.64 | - | -1.41 | -1.50 | -1.58 | -0.93 |
還原稀釋每股稅後盈餘(元) | -1.28 | -0.66 | -1.11 | -1.71 | -1.64 | -1.59 | -1.41 | -1.50 | -1.58 | -0.93 |
還原基本平均股數(千股) | 30,644 | 30,448 | 28,893 | 27,356 | 26,801 | - | 26,546 | 26,629 | 27,953 | 28,446 |
還原稀釋平均股數(千股) | 30,644 | 30,448 | 28,893 | 27,356 | 26,801 | - | 26,546 | 26,629 | 27,953 | 28,446 |
EBITDA(千元) | -22,285 | -6,087 | -19,408 | -37,580 | -39,982 | -39,807 | -35,278 | -37,083 | -41,517 | -23,255 |